- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01243229
Genetic Analysis of Congenital Diaphragmatic Disorders
March 31, 2023 updated by: Luca Brunelli, University of Utah
The purpose of this study is to understand the genetic causes of congenital diaphragmatic disorders (CDD), namely congenital diaphragmatic hernia (CDH), eventration and hiatal hernia.
Specifically, the investigators plan to:
- Ascertain informative families and sporadic cases with congenital diaphragmatic disorders and obtain appropriate phenotypic data and genetic material (peripheral blood and/or diaphragm tissue sample).
- Localize the gene(s) for CDD to specific chromosomal segments using linkage analysis, and determine the role of somatic mutations in CDD.
- Isolate and characterize genes involved in the pathogenesis of CDD.
- Develop molecular markers that will facilitate accurate diagnosis (including prenatal diagnosis) and permit correlation of phenotypic variation with specific mutations.
- Compare RNA-sequencing from tissue samples of children without CDH to those children with CDH.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
305
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Primary Children's Medical Center
-
Salt Lake City, Utah, United States, 84132
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Newborns, children and adults affected by congenital disorders of the diaphragm, such as congenital diaphragmatic hernia, eventration and hiatal hernia.
Description
Inclusion Criteria:
- Diagnosed with a congenital diaphragmatic disorder
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Genes implicated in CDD can be identified by linkage analysis
Time Frame: 5 years
|
Using the Utah Population Database, genes implicated in CDD can be identified by linkage analysis
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Develop molecular markers that will facilitate accurate diagnosis of CDD and CDH.
Time Frame: 5 years
|
Develop molecular markers that will facilitate accurate diagnosis (including prenatal diagnosis) and permit correlation of phenotypic variation with specific mutations by localizing the gene(s) for CDH to specific chromosomal segments using linkage analysis in familial cases.
In sporadic cases, characterize the role of somatic mutations in CDDs by using a candidate gene approach, and comparative genomic hybridization (CGH) arrays.
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Luca Brunelli, MD, University of Utah
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
February 28, 2018
Study Completion (Actual)
June 1, 2021
Study Registration Dates
First Submitted
November 16, 2010
First Submitted That Met QC Criteria
November 17, 2010
First Posted (Estimate)
November 18, 2010
Study Record Updates
Last Update Posted (Actual)
April 3, 2023
Last Update Submitted That Met QC Criteria
March 31, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35848
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Diaphragmatic Hernia
-
Timothy CrombleholmeRecruitingCongenital Diaphragmatic HerniasUnited States
-
University of California, San FranciscoNo longer availableSevere Congenital Diaphragmatic HerniaUnited States
-
Martin-Luther-Universität Halle-WittenbergUnknownSevere Congenital Diaphragmatic HerniaGermany
-
University of Sao Paulo General HospitalMinistry of Health, BrazilUnknownCongenital Diaphragmatic Hernia | Congenital AbnormalityBrazil
-
Connecticut Children's Medical CenterRecruitingCongenital Diaphragmatic HerniasUnited States
-
University Hospital, Strasbourg, FranceTerminatedCongenital Diaphragmatic HerniasFrance
-
University Hospital, LilleAPEHDia, a french CDH patient association; Rare Disease Foundation, FranceNot yet recruitingCongenital Diaphragmatic Hernia
-
University of California, DavisNot yet recruitingCongenital Diaphragmatic HerniaUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingCongenital Diaphragmatic HerniaBelgium
-
McGill University Health Centre/Research Institute...RecruitingCongenital Diaphragmatic HerniaCanada